Atrial fibrillation associated with subclinical hyperthyroidism

Patanè, Salvatore; Marte, Filippo

doi:10.1016/j.ijcard.2008.12.134

Cited by 9 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…35,65 It has been reported that hyperthyroidism is not associated with coronary heart disease or mortality from cardiovascular causes. 66 However, it may induce arrhythmias including AF and atrial flutter. [66][67][68] The risk for AF during a 10-year follow-up period is $10% in these patients.…”

Section: Hypercoagulability In Hypothyroidismmentioning

confidence: 99%

Thyroid Disorders and Hypercoagulability

Erem

2011

Semin Thromb Hemost

View full text Add to dashboard Cite

Various abnormalities of coagulation and fibrinolysis, ranging from subclinical laboratory abnormalities to clinically significant disorders of hemostasis, but rarely major hemorrhage or thromboembolism, may occur in patients with thyroid diseases. This review discusses the relationships between thyroid dysfunction and the coagulation/fibrinolytic system. According to the recent literature, most of the coagulation/fibrinolytic abnormalities associated with thyroid dysfunction are the consequences of direct effects of thyroid hormones on the synthesis of various hemostatic parameters. Thyroid autoimmunity may also modify the processes of secondary hemostasis. Hyperthyroidism is generally associated with hypercoagulability and hypofibrinolysis, whereas the hemostatic profile in hypothyroidism depends on the severity of the disease. Both hypercoagulable and hypocoagulable states including increased fibrinolytic activity have been reported in hypothyroidism. Few data are available on hemostasis in subclinical thyroid diseases. In conclusion, adequate further prospective clinical studies of high quality including a larges series of patients are needed to explain the degree and type of coagulation/fibrinolytic abnormalities in patients with thyroid diseases.

show abstract

Section: Hypercoagulability In Hypothyroidismmentioning

confidence: 99%

Thyroid Disorders and Hypercoagulability

Erem

2011

Semin Thromb Hemost

View full text Add to dashboard Cite

show abstract

“…Subclinical hyperthyroidism is an increasingly recognized entity that is defined as a normal serum free thyroxine and free triiodothyronine levels with a TSH level suppressed below the normal range and usually undetectable [2]. It has been reported that subclinical hyperthyroidism is not associated with coronary heart disease or mortality from cardiovascular causes [3] but it is sufficient to induce arrhythmias [2] including atrial fibrillation [4][5][6][7][8][9][10] and atrial flutter [11,12]. It has also been reported that increased factor X activity in patients with subclinical hyperthyroidism represents a potential hypercoagulable state [5,13].…”

mentioning

confidence: 99%

Hashitoxicosis with pericardial effusion

Lamari

Dattilo

Tulino

et al. 2010

International Journal of Cardiology

Self Cite

View full text Add to dashboard Cite

“…Subclinical hyperthyroidism is an increasingly recognized entity that is defined as a normal serum free thyroxine and free triiodothyronine levels with a thyroid-stimulating hormone level suppressed below the normal range and usually undetectable [4]. It has been reported that subclinical hyperthyroidism is not associated with coronary heart disease or mortality from cardiovascular causes [2] but that it is sufficient to induce arrhythmias [4] including atrial fibrillation [5][6][7][8][9][10][11][12] and atrial flutter [13,14]. Nowadays, there is growing interest regarding endogenous sublinical hyperthyroidism and the cardiovascular system [15,16].…”

mentioning

confidence: 99%